takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedemas, erfelijk - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
alunbrig
takeda pharma a/s - brigatinib - carcinoom, niet-kleincellige long - antineoplastische middelen - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
alendromono 70 mg tabl.
takeda belgium sa-nv - natriumalendronaat 76,188 mg - eq. alendroninezuur 70 mg - tablet - 70 mg - alendroninezuur 70 mg - alendronic acid
equasym xr 10 mg harde caps. geregul. afgifte
takeda pharmaceuticals international ireland branch ag - methylfenidaathydrochloride 10 mg - eq. methylfenidaat 8,65 mg - capsule met gereguleerde afgifte, hard - 10 mg - methylfenidaathydrochloride 10 mg - methylphenidate
equasym xr 20 mg harde caps. geregul. afgifte
takeda pharmaceuticals international ireland branch ag - methylfenidaathydrochloride 20 mg - eq. methylfenidaat 17,3 mg - capsule met gereguleerde afgifte, hard - 20 mg - methylfenidaathydrochloride 20 mg - methylphenidate
equasym xr 30 mg harde caps. geregul. afgifte
takeda pharmaceuticals international ireland branch ag - methylfenidaathydrochloride 30 mg - eq. methylfenidaat 25,94 mg - capsule met gereguleerde afgifte, hard - 30 mg - methylfenidaathydrochloride 30 mg - methylphenidate
equasym xr 40 mg harde caps. geregul. afgifte
takeda pharmaceuticals international ireland branch ag - methylfenidaathydrochloride 40 mg - eq. methylfenidaat 34,59 mg - capsule met gereguleerde afgifte, hard - 40 mg - methylfenidaathydrochloride 40 mg - methylphenidate
equasym xr 50 mg harde caps. geregul. afgifte
takeda pharmaceuticals international ireland branch ag - methylfenidaathydrochloride 50 mg - eq. methylfenidaat 43,24 mg - capsule met gereguleerde afgifte, hard - 50 mg - methylfenidaathydrochloride 50 mg - methylphenidate
equasym xr 60 mg harde caps. geregul. afgifte
takeda pharmaceuticals international ireland branch ag - methylfenidaathydrochloride 60 mg - eq. methylfenidaat 51,89 mg - capsule met gereguleerde afgifte, hard - 60 mg - methylfenidaathydrochloride 60 mg - methylphenidate
mezavant 1200 mg tabl. verl. afgifte
takeda pharmaceuticals international ireland branch ag - mesalazine 1200 mg - tablet met verlengde afgifte - 1200 mg - mesalazine 1200 mg - mesalazine